Every care manager in America is running the same impossible math.
More patients. Fewer clinicians. Chronic conditions that demand daily attention but receive monthly appointments. Heart failure that decompensates between visits. Hypertension that goes uncontrolled because no one is watching between the third Tuesday of every month.
This is not a staffing problem. It is a contact frequency problem.
And Cadence just raised $100 million to fix it.
On June 23, 2026, Cadence announced a Series C led by Spark Capital, bringing total funding to $241 million at a $1.23 billion valuation. The round included Thrive Capital, General Catalyst, Coatue, B Capital, and the venture arms of Corewell Health, Memorial Hermann, and Duke Health.
The company is treating 100,000 patients today with AI agents that monitor their chronic disease in real time. And it tripled annual recurring revenue in 2025.
Here is what the funding announcement obscures: this is not a remote monitoring company. Cadence is an AI-ope…
